跳至主要内容
临床试验/NL-OMON24146
NL-OMON24146已完成不适用

Optimizing Pain Treatment in Pre-Term Neonates.

Children's National Medical Center Washington0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • Preterm neonates of both genders and all races between 23 and 32 weeks postnatal age less than 30 days an indwelling (peripheral or umbilical) arterial line, and a clinical indication for intravenous morphine administration.

排除标准

  • Neonates with severe asphyxia, grade III or IV intraventricular hemorrhage, major congenital malformations/facial malformations, neurological disorders, and those receiving continuous or intermittent neuromuscular blockers.
  • Clinical or biochemical evidence of hepatic and renal compromise (including systemic hypoperfusion) or received
  • drugs that are UGT2B7 substrates (including Lorazepam, ibuprofen, valproic acid, naloxone and other morphine derivatives or propanolol).

研究者

发起方
Children's National Medical Center Washington

相似试验